Inclusion Criteria:  Men with clinically suspected prostate cancer and referred for prostate MRI Willing and able to provide a written informed consent  Exclusion Criteria:  Prostate specific antigen (PSA) level > 20ng/ml within 6 months Previous diagnosis of prostate cancer Ongoing hormone treatment within 3 months prior to MRI, excluding antiandrogens or 5-alpha reductase inhibitors Contraindication to MRI scan Contraindication to administration of gadolinium-based contrast agents